Most Innovative Companies Innovating What Matters: Driving Pharma Forward - FROM FASTCO WORKS AND PURDUE UNIVERSITY
Apr 15, 2025
Mung Chiang, President of Purdue University, is a champion for university-industry collaboration aimed at transforming the pharmaceutical landscape. He discusses how Purdue partners with companies like Elanco and Eli Lilly to foster innovation. The conversation dives into the profound effects of AI on drug discovery and manufacturing, highlighting cross-industry partnerships that tackle clinical trial challenges. Chiang emphasizes the One Health initiative and how academic startups are vital for advancing healthcare outcomes and adapting to industry needs.
AI Snips
Chapters
Transcript
Episode notes
Purdue-Lilly Partnership
- Purdue's President Mung Chiang discusses a $142 million partnership with Eli Lilly.
- This includes research funding, scholarships, and a manufacturing training facility in America's Hard Tech Corridor.
Cross-Industry Learnings
- Sean Bruick observes that data and algorithms are similar across industries.
- Lessons from digital advertising and retail can apply to biotech, like digitizing operations and data-driven decisions.
AI's Current Impact
- Tatiana Kanzaveli emphasizes that AI is already here, not just on the brink.
- She highlights using AI for drug discovery, clinical trial protocol generation, and creating synthetic data.